朱胜金;杨丹;莫阳;胡爱妮;
ZHU Shengjin;YANG Dan;MO Yang;HU Aini;Department of Laboratory,2ndAffiliated Hospital of Guiyang Traditional Medicine College;

• 1:贵阳中医学院第二附属医院检验科

摘要(Abstract)：

目的:探讨2型糖尿病(T2DM)患者血清甲状腺激素水平与糖尿病病情的关系。方法:178例T2DM患者作为糖尿病组,同时期117例健康体检人群作为对照组,分别采集糖尿病组入院时及对照组体检时清晨空腹静脉血4 m L,采用化学发光法检测游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)及促甲状腺激素(TSH)水平,采用免疫比浊法检测血清糖化血红蛋白(Hb A1c)水平;T2DM患者按Hb A1c水平和并发症再次分组,比较各组间FT3、FT4及TSH改变。结果:糖尿病组与正常对照组比较,FT3水平明显降低(P<0.01),FT4、TSH水平变化不明显(P>0.05);糖尿病患者随着Hb A1c水平增加,仅FT3呈下降趋势,组间比较差异有统计学意义(P<0.05);糖尿病并发症患者FT3水平显著低于无并发症患者(P<0.05或P<0.01)。结论:T2DM患者常伴有FT3水平降低,尤其对血糖控制不佳和有并发症的患者,FT3降低更明显。
Objective: To investigate the relationship between Type 2 diabetes mellitus with thyroid hormone( FT3、FT4、TSH) level change. Methods: A total of 178 patients with type 2 diabetes as diabetes group,117 healthy people as control group. Extracting venous blood of 2 groups,using chemiluinescence detection of serum thyroid hormone levels. Comparing two groups free three iodine thyroid glycine( FT3),free thyroxine( FT4) and thyroid stimulating hormone( TSH) changes; in patients with type 2 diabetes adopting immunoturbidimetric assay to detect Hb A1 c level. T2 DM patients will be regrouped according to Hb A1 c level and complications,in order to compare changes of FT3,FT4 and TSH. Results: Comparing Type 2 diabetes group with normal control group,FT3 level significantly decreased( P < 0. 01); no obvious difference was found between FT4 and TSH levels( P > 0. 05). With the increase of concentration of Hb A1 c,only FT3 level decreased( P < 0. 05 or P < 0. 01),FT3 level of diabetes complication group was obviously lower than no complication group( P < 0. 05 or P < 0. 01).Conclusion: Patients with type 2 diabetes often show decreased FT3 level,and patients with poor control of blood sugar and complications will lead obvious FT3 decrease.

关键词(KeyWords)： 游离三碘甲状腺原氨酸;糖尿病,非胰岛素依赖型;甲状腺激素类;糖化血红蛋白;并发症
free three iodine thyroid;diabetes mellitus,non-insulin dependent;thyroid hormones;glycosylated hemoglobin;complication

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 朱胜金;杨丹;莫阳;胡爱妮;
ZHU Shengjin;YANG Dan;MO Yang;HU Aini;Department of Laboratory,2ndAffiliated Hospital of Guiyang Traditional Medicine College;

DOI: 10.19367/j.cnki.1000-2707.2015.11.027

参考文献(References)：

• [1]梁志丽,周善存,王少波.甲状腺激素与2型糖尿病相关性分析[J].当代医学,2013(19):52-53.
• [2]王文萍,张志利.2型糖尿病伴微量白蛋白尿患者血清甲状腺激素的变化[J].中国现代医生,2011(6):42-44
• [3]周静,张士荣,严鸣,等.2型糖尿病患者血清甲状腺激素检测的临床意义[J].中华全科医学,2014(12):1990-1992.
• [4]Papazafiropoulou A.Prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic[J].J Clin Med Res,2010(2):75-78.
• [5]董靖,向大光.糖尿病与甲状腺疾病[J].临床内科杂志,2012(9):645-647.
• [6]马智鸿,武红玉,朱利国,等.2型糖尿病患者血清甲状腺激素检测的临床意义[J].国际检验医学杂志,2014(20):2767-2768.
• [7]魏迎凤,徐园园,卢学超,等.2型糖尿病颈动脉内膜中层厚度与甲状腺激素关系研究[J].中国实用内科杂志,2013(11):890-891.
• [8]Kohrle J.Thyroid hormone transporters in health and disease:advances in thyroid hormone deiodination[J].Best Pract Res Clin Endocrinol Metab,2007(2):173-191.
• [9]凌卫明,欧萌萌.2型糖尿病患者血清TGA、TPO-Ab及甲状腺激素检测的评价[J].放射免疫学杂志,2011(2):193-195.

文章评论(Comment)：